Celldex Therapeutics (CLDX) Share-based Compensation (2010 - 2026)
Celldex Therapeutics (CLDX) recorded Share-based Compensation of $8.41 million in Q2 2026, down 8.5% from $9.19 million a year earlier and down 1.3% from the prior quarter.
Powered by 
Analysis
Celldex Therapeutics (CLDX) Share-based Compensation (2010 - 2026) Analysis & Trends
On a TTM basis, Celldex Therapeutics' Share-based Compensation came in at $34.64 million as of Jun 30, 2026, down 8.6% year-over-year; for FY2025, it came in at $36.22 million, up 5.8% from FY2024.
- Annual Share-based Compensation has increased for five straight years, with a five-year compound annual growth rate of 56.0% (FY2020 to FY2025).
- Across earlier years, Share-based Compensation came in at $34.24 million in FY2024 (+43.3%), $23.89 million in FY2023 (+53.0%), $15.61 million in FY2022 (+74.4%) and $8.95 million in FY2021 (+128.7%).
- The Q2 2026 figure is the lowest quarterly Share-based Compensation since Q2 2024.
- On a year-over-year basis, Share-based Compensation has declined for four consecutive quarters, with growth averaging 10.7% over the last eight quarters.
- Peak year-over-year performance for Share-based Compensation in the last five years was growth of 149.8% in Q4 2021, against a decline of 8.9% in Q4 2025 at the low end.
- Per Business Quant, the preceding three quarters came in at $8.52 million (Q1 2026), $8.91 million (Q4 2025) and $8.8 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 458.00 Mn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 166.00 Mn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 298.00 Mn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | - |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 165.00 Mn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 231.00 Mn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 249.00 Mn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 170.20 Mn |
| 10 | Celldex Therapeutics | 2.47 Bn | 2.47 Bn | - | 8.41 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 8.41 Mn |
| Mar 31, 2026 | 8.52 Mn |
| Dec 31, 2025 | 8.91 Mn |
| Sep 30, 2025 | 8.80 Mn |
| Jun 30, 2025 | 9.19 Mn |
| Mar 31, 2025 | 9.32 Mn |
| Dec 31, 2024 | 9.78 Mn |
| Sep 30, 2024 | 9.62 Mn |
| Jun 30, 2024 | 7.64 Mn |
| Mar 31, 2024 | 7.20 Mn |
| Dec 31, 2023 | 7.21 Mn |
| Sep 30, 2023 | 7.12 Mn |
| Jun 30, 2023 | 5.22 Mn |
| Mar 31, 2023 | 4.34 Mn |
| Dec 31, 2022 | 4.51 Mn |
| Sep 30, 2022 | 4.50 Mn |
| Jun 30, 2022 | 3.45 Mn |
| Mar 31, 2022 | 3.15 Mn |
| Dec 31, 2021 | 3.14 Mn |
| Sep 30, 2021 | 3.03 Mn |
API Access
Celldex Therapeutics Share-based Compensation API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=share-based-compensation&ticker=CLDX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "share-based-compensation", "ticker": "CLDX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=share-based-compensation&ticker=CLDX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();